Advertisement

Topics

bluebird bio Statement on European Regulatory Status of LentiGlobin

18:43 EDT 25 Mar 2019 | FinanzNachrichten

A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin, blue...

Original Article: bluebird bio Statement on European Regulatory Status of LentiGlobin

NEXT ARTICLE

More From BioPortfolio on "bluebird bio Statement on European Regulatory Status of LentiGlobin"

Advertisement
Quick Search
Advertisement
Advertisement